Beau Ances

Medicine & Life Sciences

1. Alzheimer Disease 100%
2. HIV 89%
3. Brain 44%
4. Cerebrovascular Circulation 43%
5. Amyloid 42%
6. Neuroimaging 35%
7. Neurocognitive Disorders 35%
8. Magnetic Resonance Imaging 30%
9. Cognitive Dysfunction 30%
10. Positron-Emission Tomography 29%
11. Biomarkers 29%
12. 7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 27%
13. White Matter 25%
14. Cerebrospinal Fluid 23%
15. HIV Infections 19%
16. 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole 18%
17. Atrophy 17%
18. Cognition 17%
19. Nervous System 16%
20. Retroviridae Infections 15%
21. Somatosensory Cortex 13%
22. Oxygen 13%
23. Down Syndrome 12%
24. Pathology 12%
25. Mental Status and Dementia Tests 12%
26. Dementia 11%
27. Opportunistic Infections 11%
28. Therapeutics 10%
29. Central Nervous System 10%
30. Apolipoprotein E4 10%
31. Viral Load 9%
32. Disease Progression 9%
33. Lasers 9%
34. Temporal Lobe 9%
35. Encephalitis 9%
36. Highly Active Antiretroviral Therapy 8%
37. Electric Stimulation 7%
38. Deep Learning 7%
39. Connectome 7%
40. Stroke 7%
41. Gray Matter 7%
42. Tauopathies 6%
43. Virus Diseases 6%
44. Parietal Lobe 6%
45. Frailty 6%
46. Intermediate Filaments 6%
47. Machine Learning 6%
48. Hashimoto's encephalitis 5%
49. Corpus Striatum 5%
50. Neurology 5%